Fundraising Fox

Reprieve Cardiovascular

Milford, US · Founded 2020 · Delaware corporation · 4 known investors

reprievecardio.com ↗

Reprieve Cardiovascular develops therapies for heart failure patients, focusing on intelligent decongestion management to accelerate fluid removal. The company serves acute decompensated heart failure (ADHF) patients and healthcare providers globally.

HealthtechMedical Devices

Founders & leadership

HS
Hanson S. Gifford IIIDirector
TF
Tony FieldsExecutive Officer
AB
Adam BartnikExecutive Officer
MP
Mark PacynaExecutive Officer, Director
JD
Jim DillonExecutive Officer, Director
GW
Gregory W MannExecutive Officer
AE
Andrew ElBardissiDirector
JE
James EadieDirector
DN
David NeustaedterDirector
EB
Ethan BenovitzDirector
JG
Jan GarfinkleDirector

Investors · 4

Arboretum VenturesAnn Arbor · $5M – $15Mvia Jan Garfinkle · board
Lightstone VenturesPortola Valleyvia Hanson S. Gifford · board
Rex Health VenturesRaleigh · $250K – $500K
Deerfield Management CompanyreportedNew Yorkvia Andrew ElBardissi · board

Reported raises · per SEC filings

Form D private placements
▶$30.9MraisedJun 2025 · 12 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Jan GarfinkleDirector
  • Tony FieldsExecutive Officer
  • Mark PacynaExecutive Officer, Director
  • Ethan BenovitzDirector
  • James EadieDirector
  • Hanson S. Gifford IIIDirector
  • Adam BartnikExecutive Officer
  • David NeustaedterDirector
Offering amount
$35.9M
Amount sold
$30.9M
First sale
May 2025
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$9.5MraisedJan 2025 · 8 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • James EadieDirector
  • Tony FieldsExecutive Officer
  • Adam BartnikExecutive Officer
  • David NeustaedterDirector
  • Ethan BenovitzDirector
  • Mark PacynaExecutive Officer, Director
  • Hanson S. Gifford IIIDirector
  • Jan GarfinkleDirector
Offering amount
$10.5M
Amount sold
$9.5M
First sale
Sep 2024
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$12.1MraisedNov 2023 · 7 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • David NeustaedterDirector
  • Gregory W. MannExecutive Officer
  • Ethan BenovitzDirector
  • Mark PacynaExecutive Officer, Director, Promoter
  • Jan GarfinkleDirector
  • Tony FieldsExecutive Officer
  • James EadieDirector
  • Hanson S. Gifford IIIDirector
Offering amount
$12.1M
Amount sold
$12.1M
First sale
Nov 2023
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$15MraisedJun 2022 · 6 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Hanson S. Gifford IIIDirector
  • Andrew ElBardissiDirector
  • Ethan BenovitzDirector
  • Gregory W. MannExecutive Officer
  • Mark PacynaExecutive Officer
  • James EadieDirector
  • Jim DillonExecutive Officer, Director
Offering amount
$15M
Amount sold
$15M
First sale
Apr 2022
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$15MraisedAug 2020 · 6 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Jim DillonExecutive Officer, Director
  • James EadieDirector
  • Ethan BenovitzDirector
  • Hanson S Gifford IIIDirector
  • Gregory W MannExecutive Officer
  • Andrew ElBardissiDirector
Offering amount
$15M
Amount sold
$15M
First sale
Jul 2020
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.